Purple Biotech Ltd.PPBTNASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank79
Year-over-Year Change
Year-over-year book value per share growth
Percentile
P79
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | -1.56% |
| Q2 2025 | -5.68% |
| Q1 2025 | -22.59% |
| Q4 2024 | -5.68% |
| Q3 2024 | -20.31% |
| Q2 2024 | -6.95% |
| Q1 2024 | -14.48% |
| Q4 2023 | -24.38% |
| Q3 2023 | -12.86% |
| Q2 2023 | -14.19% |
| Q1 2023 | -7.41% |
| Q4 2022 | -11.17% |
| Q3 2022 | -6.84% |
| Q2 2022 | -5.47% |
| Q1 2022 | 2.13% |
| Q4 2021 | -19.08% |
| Q3 2021 | -3.77% |
| Q2 2021 | -4.74% |
| Q1 2021 | -98.49% |
| Q4 2020 | -77.31% |
| Q3 2020 | 13405.88% |
| Q2 2020 | 0.00% |
| Q1 2020 | 139.51% |
| Q4 2019 | -29.76% |
| Q3 2019 | -6.85% |
| Q2 2019 | 0.00% |
| Q1 2019 | -13.28% |
| Q4 2018 | -3.55% |
| Q3 2018 | -17.06% |
| Q2 2018 | -4.22% |
| Q1 2018 | 11.99% |
| Q4 2017 | -15.84% |
| Q3 2017 | -37.48% |
| Q2 2017 | -10.35% |
| Q1 2017 | -3.74% |
| Q4 2016 | -1.88% |
| Q3 2016 | -0.19% |
| Q2 2016 | -2.56% |
| Q1 2016 | -55.56% |
| Q4 2015 | 1955.13% |